Gene-repressing epigenetic reader EED unexpectedly enhances cyclinD1 gene activation
Molecular Therapy - Nucleic Acids · 2023-03 · 31 · 717-729
DOI: 10.1016/j.omtn.2023.02.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy - Nucleic Acids, 2023-03. Verfasst von Mengxue Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Institutes of Health, National Heart Lung and Blood Institute.
Abstract (Originalsprache)
Epigenetically switched, proliferative vascular smooth muscle cells (SMCs) form neointima, engendering stenotic diseases. Histone-3 lysine-27 trimethylation (H3K27me3) and acetylation (H3K27ac) marks are associated with gene repression and activation, respectively. The polycomb protein embryonic ectoderm development (EED) reads H3K27me3 and also enhances its deposition, hence is a canonical gene repressor. However, herein we found an unexpected role for EED in activating the bona fide pro-proliferative gene Ccnd1 (cyclinD1). EED overexpression in SMCs increased Ccnd1 mRNA, seemingly contradicting its gene-repressing function. However, consistently, EED co-immunoprecipitated with gene-activating H3K27ac reader BRD4, and they co-occupied at both mitogen-activated Ccnd1 and mitogen-repressed P57 (bona fide anti-proliferative gene), as indicated by chromatin immunoprecipitation qPCR. These results were abolished by an inhibitor of either the EED/H3K27me3 or BRD4/H3K27ac reader function. In accordance, elevating BRD4 increased H3K27me3. In vivo, while EED was upregulated in rat and human neointimal lesions, selective EED inhibition abated angioplasty-induced neointima and reduced cyclinD1 in rat carotid arteries. Thus, results uncover a previously unknown role for EED in Ccnd1 activation, likely via its cooperativity with BRD4 that enhances each other's reader function; i.e., activating pro-proliferative Ccnd1 while repressing anti-proliferative P57. As such, this study confers mechanistic implications for the epigenetic intervention of neointimal pathology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
- Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA 22908, USA.
- Center for Public Health Genomics, University of Virginia, Charlottesville, VA 22908, USA.
- Department of Public Health Sciences, University of Virginia, Charlottesville, VA 22908, USA.
- Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908, USA.
- Department of Molecular Physiology and Biological Physics, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
Förderung
- NHLBI NIH HHS
- National Institutes of Health
- National Heart Lung and Blood Institute
- American Heart Association
Zitieren
APA
Zhang, M., Li, J., Wang, Q., Urabe, G., Tang, R., Huang, Y., Mosquera, J. V., Kent, K. C., Wang, B., Miller, C. L., & Guo, L. W. (2023). Gene-repressing epigenetic reader EED unexpectedly enhances cyclinD1 gene activation. Molecular Therapy - Nucleic Acids, 31, 717-729. https://doi.org/10.1016/j.omtn.2023.02.024
Vancouver
Zhang M, Li J, Wang Q, Urabe G, Tang R, Huang Y, et al. Gene-repressing epigenetic reader EED unexpectedly enhances cyclinD1 gene activation. Molecular Therapy - Nucleic Acids. 2023;31:717-729. doi:10.1016/j.omtn.2023.02.024
BibTeX
@article{Zhang2023,
author = {Zhang, Mengxue and Li, Jing and Wang, Qingwei and Urabe, Go and Tang, Runze and Huang, Yitao and Mosquera, Jose Verdezoto and Kent, K Craig and Wang, Bowen and Miller, Clint L and Guo, Lian-Wang},
title = {Gene-repressing epigenetic reader EED unexpectedly enhances cyclinD1 gene activation},
journal = {Molecular Therapy - Nucleic Acids},
year = {2023},
volume = {31},
pages = {717--729},
doi = {10.1016/j.omtn.2023.02.024}
}
EUVIMED